James C. Hamilton, Chief Discovery/Trans Medicine: Arrowhead Pharmaceuticals ARWR Sell · Filed 24/01/17

Trade details

Type: Insider sale
Amount: $154,559.86
Shares · price: 4,238 sh · $36.47 a share
Held after: 214,553 sh
Stock: Arrowhead Pharmaceuticals ARWR
Person: James C. HamiltonChief Discovery/Trans Medicine
Trade date: 24/01/12
Filed: 24/01/17
Days to filing: 5 days

Sold 1.9% of holdings

Share of holding sold: 1.9%

Arrowhead Pharmaceuticals trades, last 26 weeks

What else happened in Arrowhead Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/12/13~24/02/11

James C. Hamilton's recent trades

James C. HamiltonChief Medical Officer
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$750K
10,000 sh
$750K
Filed 04/24
Traded 04/23
James C. HamiltonChief Medical Officer
Planned saleArrowhead Pharmaceuticals
Planned sale
Arrowhead Pharmaceuticals
ARWR
$750K
10,000 sh
$750K
Filed 04/23
Traded 04/23
James C. HamiltonChief Medical Officer
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$641.9K
10,000 sh
$641.9K
Filed 03/09
Traded 03/05
James C. HamiltonChief Medical Officer
Planned sale10b5-1 planArrowhead Pharmaceuticals
Planned sale10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$641.9K
10,000 sh
$641.9K
Filed 03/05
Traded 03/05
James C. HamiltonChief Medical Officer
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$932K
14,792 sh
$932K
Filed 01/05
Traded 01/05

James C. Hamilton, Chief Officer — sold $154.6K of Arrowhead Pharmaceuticals ARWR · 1.9% of holdings · 10b5-1 plan | Whalegun